OBIO
Orchestra BioMed Holdings, Inc.
Orchestra BioMed Holdings, Inc. (OBIO) has 17 SEC Form 4 filings (21 transaction rows) in the rolling window, disclosed by 5 distinct insiders. Most recent filing: Jul 2, 2026.
- Industry:Biotechnology
- CEO:David Hochman
- Employees:86
- HQ:New Hope, PA, US
- IPO:2020-08-04
Insider Buying
$158K
reported purchases (SEC code P)
Insider Selling
$122K
reported sales (SEC code S)
Unique Insiders
5
in the rolling window
Market Cap
$218.0M
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
| See Remarks | Sale | 15,000 | $64K | Jul 2 | SEC ↗ | |
Sherman DarrenFirst filing | See Remarks | Sale | 15,000 | $58K | Jun 2 | SEC ↗ |
| See Remarks | Purchase | 5,000 | $19K | Jun 2 | SEC ↗ | |
| Director | Purchase | 665 | $2K | May 20 | SEC ↗ | |
Hochman David PFirst filing | See Remarks | Purchase | 5,000 | $19K | May 19 | SEC ↗ |
Aryeh JasonFirst filing | Director | Purchase | 8,971 | $35K | May 19 | SEC ↗ |
Fain Eric SFirst filing | Director | Purchase | 20,000 | $83K | May 18 | SEC ↗ |
RTW INVESTMENTS, LPFirst filing | Insider | Sale | 32 | $132 | Apr 29 | SEC ↗ |
Related companies
Orchestra BioMed Holdings, Inc. is in the Healthcare sector.